Danaher to buy protein consumables provider Abcam for $5.7bn
Abcam, a UK-based provider of protein-based antibodies, reagents, biomarkers, and assays, will operate as a standalone company and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Aug 23
Abcam, a UK-based provider of protein-based antibodies, reagents, biomarkers, and assays, will operate as a standalone company and…
14 Aug 23
As part of the collaboration, Logomix will initially contribute genome editing capabilities to assist HebeCell in creating the…
11 Aug 23
The investment will help Astellas to establish a significant presence in life science innovation hotspots in the world…
14 Jul 23
The acquisition allows Applied DNA Sciences to leverage its LinearDNA platform, which enables efficient chemical modification of DNA…
13 Jul 23
Merck will expand its cell culture media production capacity at the Lenexa facility, by installing a new dry…
22 Jun 23
Transformation has resulted in Ellab tripling its revenues, EBITDA and number of employees, while experiencing approximately 20% annual…
16 Jun 23
Since its initial listing, Viva Biotech has successfully completed mergers and acquisitions, including SYNthesis and Langhua Pharmaceutical, resulting…
01 Jun 23
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing…
05 Apr 23
Certest Biotec, a biotech company based in San Mateo de Gállego, is committed to R&D as a driving force for
15 Mar 23
Through our deep technical knowledge and long-standing experience in the agri/food industry, Sonata is well-positioned to help customers…